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Abstract
As of November 1, 2020, estimated case-fatality rates associated with coronavirus disease 2019
are not uniformly patterned across the world and differ substantially in magnitude. Given the
global spatial heterogeneity in case-fatality rates, we applied the Blinder-Oaxaca regression
decomposition technique to identify how putative sociodemographic, structural, and
environmental sources influence variation in case-fatality rates. We show that compositional and
associational differences in country-level risk factors explain a substantial proportion of the
coronavirus disease 2019-related case-fatality rate gap across nations. Asian countries fair better
vis-à-vis case-fatality rate differences mainly due to variation in returns to sociodemographic,
structural, and environmental sources among their citizens, relative to those who share similar
attributes but live in Europe or North America. The variation in case-fatality rate is driven by
Asian populations being better able to buffer the harmful effects of the very risk factors
purported to exacerbate the risk of coronavirus disease 2019-related death. The dire
circumstances in which we find ourselves demand better understanding of how preexisting
conditions across countries contribute to observed disparities in case-fatality rates.
Keywords: Covid-19; SARS-CoV-2; communicable disease; pandemic; statistics; risk factor
Word Count: 3, 513
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Disclosure Statement: Authors declare no conflicts of interest.
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Introduction
In January 2020, Chinese health authorities identified severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) as the causative agent for a cluster of pneumonia cases initially
detected in December of 2019 in the city of Wuhan1. Since then, the incidence of coronavirus
disease 2019 (Covid-19), the illness caused by SARS-CoV-2, has risen exponentially2. By midMarch 2020, Covid-19 spread across the world, albeit with substantial global spatial
heterogeneity in the number of reported cases across different countries3. Related, the reported
Covid-19-related case-fatality rates (CFR), defined as the number of deaths in persons who
tested positive for SARS-CoV-2 divided by the number of SARS-CoV-2 cases, differ
substantially in magnitude, from an estimated 0.27% in Singapore, 2.16% in South Korea, and
2.86% in Germany to 10.46% in Spain and 13.95% in Belgium4.
Also relevant are the sociodemographic, structural, and environmental risk factors
associated with Covid-19-related CFR. For example, Covid-19 is substantially more lethal in
older persons, and CFR rises sharply with age, from an estimated 0.02%–0.32% in the 30–39 age
group and 1.12%–10.89% in the 60–69 age group, to 5.68%–26.69% in the 70–79 age group and
13.4%–38.44% in those aged 80 years or older5-8. In addition to the devastating impact of Covid19 on the elderly, individuals with obesity are greatly affected by SARS-CoV-2 in terms of the
risk of hospitalization9. One of the more readily predictable risk factors for infectious disease
transmission is higher population density, which may, in part, account for geographic differences
in numbers of COVID-19 cases10. With regard to the environmental risk factors, long-term
exposure to higher concentrations of ambient air pollutants such as particulate matter (PM2.5) is a
potent driver of the observed upward trend in Covid-19-related CFR11. To minimize viral
transmission and keep mortality rates exacerbated by these risk factors as low as possible,
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governments around the world instituted a number of mitigation efforts, including physical
distancing, school and workplace closures, cancelation of large-scale public gatherings, and stayat-home orders12,13.
The above cited reports emphasize the association between Covid-19-related CFR and
sociodemographic and environmental risk factors. However, researchers have yet to completely
account for the estimated CFR disparities across countries. To this end, and given the irregular
spatial patterning in CFR, we examine putative sociodemographic, structural, and environmental
drivers of higher CFR estimates across seventeen nations affected by the Covid-19 pandemic3.
We acknowledge that CFR will likely shift in response to improved testing and reporting
practices, and thus, over time, enable the emergence of more accurate and useful data4. Still, we
use the latest data available to us as this devastating pandemic continues to unfold3.
Methods
In our analyses, we used cumulative counts of SARS-CoV-2 diagnosed infections and
deaths attributable to Covid-19 reported by the European Centre for Disease Prevention and
Control (ECDC) during January 13, 2020– November 1, 2020 for the following nations (in
alphabetical order, and grouped by geographic regions): Hong Kong, Japan, South Korea, and
Taiwan (Eastern Asia); Malaysia, Singapore, and Thailand (South-eastern Asia); United
Kingdom (Northern Europe); Italy and Spain (Southern Europe); Belgium, France, Germany,
Netherlands, and Switzerland (Western Europe); and Canada and the United States (North
America)3. We included data starting with January 13, 2020 when Thailand recorded its first
Covid-19 case, which is the earliest recorded case across all of the nations under study3. In terms
of total cases and fatalities attributable to Covid-19, the above listed European and North
American countries find themselves atop the list of countries most heavily impacted by the
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pandemic3. Conversely, the above mentioned Eastern and South-eastern Asian countries are
some of the least affected countries, both in terms of the total number of diagnosed infections
and deaths attributable to Covid-193.
We captured SARS-CoV-2-related fatalities using Covid-19 CFR, defined as the ratio of
Covid-19-related deaths divided by the number of Covid-19 diagnosed cases5,14. We included
multiple factors that likely associate with higher CFR, including median age15, percent of the
population that is female16, percent classified as obese17, percent with asthma18, smoking
prevalence19, percent with high blood pressure20, percent with diabetes18, PM2.5 mean annual
exposure21, number of hospital beds per 1000 individuals22, and population density23. Many of
these factors are highly correlated, and thus we represented them in a more parsimonious way by
taking the first dimension of a principal components factor analysis that weighted each variable
based upon its factor loading. All loadings exceed 0.40, eigenvalue is > 1, and internal
consistency, as measured by Cronbach's α, is 0.533 (Table 1). We defined this newly constructed
measure as country-level “risk.” Time is a continuous measure defined in number of days since
the earliest recorded case across all nations under study. Our entire study period is 294 days:
January 13, 2020–November 1, 2020. Exploratory analyses indicated that CFR is most
appropriately captured by a quadratic function due to the non-linear relationship between CFR
and time. As such, we only present estimates with the quadratic time term included. We also
included a physical distancing measure denoted as a time-ordered series of dichotomous
variables based on school closure dates24 to account for variation in the enactment of behavioral
mitigation strategies across countries. This physical distancing measure equals 1 if schools were
closed on a given date and 0 if otherwise.
<Table 1>
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We used the Blinder-Oaxaca regression decomposition technique to identify the sources
of Covid-19-related differences in CFR across countries25-29. Our modeling approach permits
decomposition between two groups only25-29. Accordingly, the populations under study were
grouped into ‘high-mortality-low-risk’ (i.e., relatively more impacted; the United States, United
Kingdom, Italy, France, Spain, Belgium, Germany, Canada, the Netherlands, Switzerland) and
‘low-mortality-high-risk’ (i.e., relatively less impacted; Taiwan, Hong Kong, Singapore,
Malaysia, Thailand, South Korea, Japan), based upon the cumulative number of reported Covid19-related deaths as of November 1, 2020. More specifically, high-mortality-low-risk countries
fall within the 4th quartile, and low-mortality-high-risk countries between the 1st and 3rd quartile,
based upon the total number of fatalities within a country across all the countries in the world, up
to November 1, 20203. As an example, Switzerland (high-mortality-low-risk) and Taiwan (lowmortality-high-risk) recorded a total of 2,097 and 7 deaths by November 1, 2020, respectively,
despite the fact that Switzerland has a population about one-third the size of Taiwan3. Moreover,
United Kingdom (high-mortality-low-risk) and Thailand (low-mortality-high-risk) recorded a
total of 46,555 and 59 deaths by November 1, 2020, respectively, despite having similar
population sizes3. We defined the ‘high-mortality-low-risk’ designation as the reference group to
ensure our estimates from the original Blinder-Oaxaca method are unbiased27. To explain the
difference in CFR between the two groups (i.e., high-mortality-low-risk versus low-mortalityhigh-risk), we used a stepwise process, and stratification was necessary in each step25-29.
The first step in partitioning the CFR gap is to estimate the sample means for highmortality-low-risk and low-mortality-high-risk group covariates to identify differences between
country groupings. In the second step, we estimated separate regression equations by country
grouping (i.e., high-mortality-low-risk and low-mortality-high-risk) and then used the estimated
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coefficients and intercept from each of these regression equations, as well as the sample means
for the covariates estimated in step one, to compute two counterfactuals. The first counterfactual
quantifies how CFR would have differed if compositional differences by country consisted of the
compositional makeup of high-mortality-low-risk countries and if the regression coefficients did
not differ (i.e., the regression coefficients for high-mortality-low-risk and low-mortality-highrisk countries are the same). This addresses whether differences in CFR exist between country
groupings because, for example, asthma is more prevalent among citizens in European and North
American (high-mortality-low-risk) countries, compared with asthma prevalence among citizens
in Asian (low-mortality-high-risk) countries. Thus, the value of the first counterfactual represents
the contribution of differences in the mean levels of the covariates between the country
groupings (i.e., differences in compositional makeup of high-mortality-low-risk and lowmortality-high-risk countries).
The second counterfactual quantifies how CFR would have differed if the regression
coefficients and intercept differed as they did between the two country groupings and if the
compositional makeup of countries did not differ (i.e., the means between high-mortality-lowrisk and low-mortality-high-risk countries are the same). This addresses whether CFR
differences exist between country groupings because citizens in high-mortality-low-risk
countries, for example, are less able to reduce personal health risks from exposure to air
pollutants due to a lack of resources (e.g., inability to clean indoor air with air filters), relative to
those citizens in low-mortality-high-risk countries. The value of the second counterfactual
represents the contribution of differences in the regression coefficients and intercepts between
high-mortality-low-risk and low-mortality-high-risk countries (i.e., differences in associations or
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magnitude of determinants). The decomposition is estimated from the “perspective” of highmortality-low-risk countries.
Results
Table 2 displays means and standard deviations for independent and dependent variables
by country grouping [i.e., high-mortality-low-risk (Belgium, Canada, France, Germany, Italy, the
Netherlands, Spain, Switzerland, United Kingdom, the United States) and low-mortality-highrisk (Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand)]. The difference
in CFR may be a consequence of differences in the population composition of high-mortalitylow-risk and low-mortality-high-risk countries. CFR varies significantly by country grouping
designation, with high-mortality-low-risk country group estimation higher than low-mortalityhigh-risk. Examples of this divergence are shown in Supplemental Figures 1 and 2 where we plot
the change in CFR over time during the length of our study period separately for high-mortalitylow-risk and low-mortality-high-risk countries.
<Table 2>
< Supplemental Figure 1>
< Supplemental Figure 2>
Nearly all population-level risk factors purported to increase Covid-19-related CFR vary
significantly across country groupings, aside from the percentage of females in the population.
More specifically, in low-mortality-high-risk countries a greater proportion of the population
suffers with hypertension (high-mortality-low-risk: 17.78% vs. low-mortality-high-risk: 19.33%)
and diabetes (high-mortality-low-risk: 6.28% vs. low-mortality-high-risk: 9.61%). Population
density is higher in low-mortality-high-risk (2448.61 per square mile) countries, compared to
high-mortality-low-risk (204.68 per square mile) countries. Median age is 43.07 in high-
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mortality-low-risk countries and 41.47 years of age in low-mortality-high-risk countries. Highmortality-low-risk, relative to low-mortality-high-risk, countries have a lower overall estimated
risk score (-0.22 vs. 0.54, respectively). It is worth noting that despite variation in the means
across the very risk factors purported to drive case-fatality rates, CFR averages remain highest in
country groupings that score the lowest across many of these risk factors (see the upper and
lower portions of Table 2). Appendix 1 presents a breakdown of the means and standard
deviations for these risk factors by country. Additionally, as shown, the date of enactment of
physical distancing measures (i.e., date of school closures) varies significantly across countries,
from January 25, 2020 in Hong Kong (low-mortality-high-risk) and March 2, 2020 in Japan
(low-mortality-high-risk) to March 20, 2020 in United Kingdom (high-mortality-low-risk) and
April 1, 2020 in Canada (high-mortality-low-risk)24.
<Appendix 1>
<Table 2>
CFR may also vary by country grouping because the associations between populationlevel risk factors and CFR differ. Table 3 displays the estimated coefficients from Ordinary Least
Squares (OLS) models regressing CFR on risk while accounting for variation in population
density, time, and timing of the enactment of physical distancing measures (i.e., school closure
dates).
<Table 3>
The initial estimated CFR is significantly different between country groupings and is
greater in magnitude in low-mortality-high-risk countries (2.15, p<0.001), relative to highmortality-low-risk countries (-7.64, p<0.001). With the passage of time, CFR increases in highmortality-low-risk and low-mortality-high-risk country groupings, as evidenced by the positive
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values for the linear components of the time slope (0.21 and 0.01, p<0.001), and the negative
values for the quadratic components of the time slope (-0.00 and -0.00, p<0.001). Both country
groupings indicate non-linearity in the time trend. Regression estimates indicate further that the
early enactment of physical distancing measures led to a 0.23-point reduction in CFR among
high-mortality-low-risk countries (p<0.001), while resulting in a lower magnitude decline of
CFR in low-mortality-high-risk countries (-0.20, p<0.001). The associations between risk and
CFR differ significantly between country groupings. As risk increases, CFR significantly
increases, on average, by 0.17 points in low-mortality-high-risk countries (p<0.01), whereas
high-mortality-low-risk countries see a significant decrease of -2.61 (p<0.001).
The Blinder-Oaxaca results are displayed in Table 4. We present the unique contributions
of compositional and associational effects on the total CFR difference between country
groupings attributable to the population-level sociodemographic, structural, and environmental
factors. Again, in our model, we conceptualized these factors as “risk.” The interaction term
reflects the fact that differences in endowments and differences in the associations between
covariates and CFR occur together28. Some studies incorporate this interaction term into either
the associational or compositional portion of the decomposition29, but we retain the interaction
term because it provides a more conservative test of the relative importance of differences in
country compositions and associations. Moreover, prior theory on CFR does not generate
specific hypotheses regarding the interaction between differences in compositions and
associations. As such, we refrain from interpreting the interaction term.
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<Table 4>
The CFR differs by 6.30% between the two country groupings (7.84 in high-mortalitylow-risk and 1.54 in low-mortality-high-risk; p<0.001). Population compositional differences
explain a small but significant proportion of the CFR variation between country groupings
(0.54%, p<0.001) indicating that compositional differences, designated here as ‘risk’, contribute
to CFR disparities between high-mortality-low-risk and low-mortality-high-risk countries. As an
example, because higher proportions of people suffer with obesity in the United States and
United Kingdom (both high-mortality-low-risk), relative to Japan and Singapore (both lowmortality-high-risk) (i.e., differences in sample means shown in Table 2), there is a higher
percentage of the population at risk for this factor purported to exacerbate Covid-19-related CFR,
and this difference contributes to the variation in CFR between country groupings. Still, it is
beyond the scope of our analysis to disentangle which of these factors drive this variation given
our use of a factor analysis to more parsimoniously represent these highly collinear measures of
risk.
The principal factor responsible for the difference in CFR between high-mortality-lowrisk and low-mortality-high-risk countries is the differences in the associations between country
groupings and the included population-level risk factors (10.65%, p<0.001). Indeed, the
difference attributable to factors conceptualized as “risk” in our models (i.e., median age, percent
of the population that is female, percent classified as obese, percent with asthma, smoking
prevalence, percent with high blood pressure, percent with diabetes, PM2.5 mean annual
exposure, and number of hospital beds per 1000 individuals), while holding population density,
time, and physical distancing enactment differences (i.e., school closure dates) constant, is
significantly linked to CFR variation. In fact, as shown in Table 4, net of other factors, some of
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which counteract the positive effect of difference in CFR, variation in the coefficients for the
sociodemographic, structural, and environmental characteristics, defined here as “risk”, explains
a greater proportion of country-level disparities between high-mortality-low-risk and lowmortality-high-risk countries than compositional differences between country groupings. This
variation in CFR is linked comparatively more to differences in the estimated coefficients for
risk in our models. In short, our decomposition indicates that despite greater “risk” among
citizens of low-mortality-high-risk nations, these differences are not driving CFR disparities
across country groupings. Instead, preexisting inequities in high-mortality-low-risk countries
seem to create an environment wherein an individual diagnosed with Covid-19 may be less able
to buffer the harmful effects of viral infection, leading to higher CFR in these nations. For
illustrative purposes, in Supplemental Figure 3, we graphed the mean CFR change over time
during the length of our study period for high-mortality-low-risk and low-mortality-high-risk
country groupings. Moving from left to right in Supplemental Figure 3, the average CFR gap
widens over time between high-mortality-low-risk and low-mortality-high-risk country
groupings. More specifically, mean CFR increases from a low of 0.2% (February 24, 2020) to a
high of 11.4% (May 25, 2020) in high-mortality-low-risk countries, and from 1.2% to 1.8% in
low-mortality-high-risk countries, during that same time period.
< Supplemental Figure 3>
Discussion
Overall, our results for January 13– November 1, 2020, confirm that the Covid-19-related
case-fatality rate (CFR) is higher across European and North American (high-mortality-low-risk)
nations than that observed in the Asian (low-mortality-high-risk) populations under study, as was
shown previously4,5,14. We add to this literature by providing evidence that compositional and
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associational differences in country-level social (median age, obesity prevalence, percent with
diabetes, percent with hypertension, asthma prevalence, population density), structural (number
of hospital beds per 1000 individuals), and environmental (ambient air pollution) factors,
conceptualized as “risk”, explain a substantial proportion of the Covid-19-related CFR gap
across country groupings (i.e., high-mortality-low-risk vs. low-mortality-high-risk). Importantly,
despite that compositional differences explain only a small share of the overall CFR gap between
high-mortality-low-risk and low-mortality-high-risk countries, variation in CFR averages remain
highest in countries that score the lowest across these risk factors.
Relatedly, we show that Asian countries (low-mortality-high-risk) fair better, vis-à-vis
Covid-19-related CFR, even with the higher observed risk score, relative to high-mortality-lowrisk countries. CFR is lower in Asian, relative to European and North American, nations partially
because the magnitude of the association attributable to country-level characteristics is higher in
Europe and North America. This variation may be driven by low-mortality-high-risk populations
being better able to buffer the harmful effects of sociodemographic, structural, and
environmental factors that exacerbate the risk of Covid-19-related death, leading to lower overall
CFR, relative to European or North American (high-mortality-low-risk) nations. The difference
in returns to sociodemographic, structural, and environmental characteristics among citizens in
Asian nations, relative to those populations who share similar circumstances but live in Europe
or North America, contributes to the observed disparities in CFR. This latter finding clearly
underscores the importance of relating social determinants of health to “risk”, but it is beyond the
scope of our analysis to parse out which of the factors matter most. Still, we offer some potential
explanations.

13

Lessons learned from Singapore, for example, show that early intervention and
widespread availability of diagnostic tests is paramount30. The earlier the identification and
isolation of persons infected with SARS-CoV-2, the better the control of transmission30. Early
detection is likely to lead to less severe clinical outcomes, and possibly decrease the risk of death
from Covid-1930. Moreover, widespread surveillance testing enables faster contact tracing, which
is a mainstay of infectious disease control31. It is also worth noting that since the outbreak of
SARS-CoV-2 the uncertainty about the efficacy of surgical masks to reduce virus transmission
among the general public has resulted in inconsistent recommendations by health authorities in
different countries about the widespread use of face masks32. Consequently, the use of face
masks in public was, in part, influenced by social norms and values already embedded in the
cultural background of nations33. In many Asian countries mask-wearing is destigmatized and is
commonplace since 2003 as SARS spread around China and neighboring countries33. The latter
point is significant because face masks may result in a large reduction in risk of infection34.
Related, governments of Hong Kong and Singapore built a more robust public health system
following the outbreak of H5N1 avian influenza in 1997 and H1N1 influenza in 2009, which, in
part, enabled a more efficient response to the current Covid-19 pandemic33.
To the best of our knowledge, this is the first study that employed Blinder-Oaxaca
regression decomposition technique25-29 to identify the sources of Covid-19-related differences in
CFR across countries. This study, however, is not without limitations. The published reports
indicate that, especially during the early phase of Covid-19 outbreak, limited diagnostic testing
and hospital bed capacity, and testing or reporting delays may influence the number of daily
reported cases across countries35. However, for countries in our sample with data available, the
Covid-19 incidence curve parallels the growth rate of deaths and hospitalizations36-40, two
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measures that may be a less biased metric of a Covid-19 outbreak35, giving us confidence in the
estimates presented here. Related, we were unable to control for the amount of testing across
countries because some governments report the number of Covid-19 tests performed (e.g.,
Belgium, France, Germany, Hong Kong, Spain, Switzerland, Thailand, United Kingdom, the
United States), while others report the number of people tested (e.g., Canada, the Netherlands,
Taiwan)41. For example, as of November 2, 2020, in Singapore, a total of 1.1 million unique
persons were swabbed, and a total of 3.8 million swabs were tested42. Theoretically, then, since
the same person may be tested more than once, the number of tests performed may be higher.
Additionally, our sample is restricted to seventeen nations and data are drawn from six
geographic regions, thus reducing the generalizability of our findings to a particular portion of
people in Eastern Asia, South-eastern Asia, Northern Europe, Southern Europe, Western Europe,
and North America through November 1, 2020. Also, given that dates of the first recorded case
differ across countries3 [e.g., Thailand (low-mortality-high-risk) on January 13, 2020, Japan
(low-mortality-high-risk) on January 16, 2020, the United States of America (high-mortalitylow-risk) on January 21, 2020, and the Netherlands (high-mortality-low-risk) on February 27,
2020], and we include data starting with January 13, 2020, when Thailand recorded its first
Covid-19 case (i.e., the earliest recorded case across all of the nations under study)3, our
estimates may be attenuated. Finally, although government officials across the world enacted a
number of personal protective behaviors such as social distancing, workplace closures,
cancelation of large-scale public gatherings, and stay-at-home orders13,30,31, we used school
closure dates24 to account for variation in the enactment of behavioral mitigation efforts across
countries. We opted to use this measure given that governments worldwide introduced school
closures early on in their initial response to the SARS-CoV-2 outbreak43.
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Despite these limitations, we are the first to show that citizens of the Asian nations under
study are exposed to higher levels of social, structural, and environmental risk, relative to
European and North American countries included in our analyses. Yet, these differences in risk
are not driving CFR disparities across countries. Instead, preexisting sociodemographic,
structural, and environmental inequities in European and North American nations seem to create
an environment wherein an individual diagnosed with Covid-19 may be less able to buffer the
harmful effects of viral infection, leading to higher rates of Covid-19-related mortality.
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Table 1. Results from the First Loading of a
Principal Components Factor Analysis (Data
are from 2016-2017 Our World in Data and
the World Bank)
Variable
Risk
Mean PM2.5
Obesity Prevalence
Daily Smoking Prevalence
Asthma Prevalence
Percent High Blood Pressure
Diabetes Prevalence
Percent of Total Population Female
Median Age
Hospital Beds per 1k
Eigenvalue
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Factor
0.55
0.43
-0.70
-0.40
0.54
0.79
0.42
-0.56
-0.44
2.73

Table 2: Means and Standard Deviations for Independent and Dependent Variables by Country Type,
January 13 - November 1, 2020

Dependent Variable
Case Fatality Rate (CFR)
Cumulative Deaths
Cumulative Cases
Independent Variables
Time
Time2
Daily Smoking Prevalence
Asthma Prevalence
Percent High Blood Pressure
Diabetes Prevalence
Percent of Total Population
Female
Mean PM2.5
Obesity Prevalence
Median Age
Hospital Beds per 1k
PCFA 'Risk' Score
Population Density
Physical Distancing Date Range

High-Mortality-LowRisk
Mean
SD
7.84
5.13
25156.23
41150.37
499456.10 1337081.00
165.34
32838.70
25.40
5.85
17.78
6.28

Low-MortalityHigh-Risk
Mean
SD
1.54
2.03
202.62
364.54
14976.52 21070.23

Diff.
***
***
***

74.19
25032.15
5.06
1.46
3.00
2.02

159.52
79.94
31832.29 25791.12
19.04
4.07
4.73
0.25
19.33
5.57
9.61
3.58

***
***
***
***
***
***

50.67
0.29
12.05
2.75
24.34
5.07
43.07
2.77
4.50
1.83
-0.22
0.39
204.68
146.41
3.20. - 4.01.2020

50.65
1.50
23.12
7.17
13.07
13.46
41.47
5.43
6.76
4.92
0.54
1.17
2448.61 3247.81
1.25. - 3.02.2020

***
***
***
***
***
***
***

Source: Data are from the European Centre for Disease Control and Prevention, World Bank, Our World in Data, UNESCO Global
Education Coalition, and the World Health Organization
Note: Asterisks indicate significant difference evaluated using two-tailed independent means t-test by country type
Note: PCFA = Principal Components Factor Analysis
*p <.05, **p <.01, ***p<.001
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Table 3: OLS Regression Estimates For Covid-19-Related Case Fatality Rates by Country
Type, January 13 - November 1, 2020 ; N = 4,098
High-Mortality-Low
Low Mortality-HighRisk
Risk
Coeff.
St. Err.
Coeff.
St. Err.
Intercept
-7.64***
0.39
2.15***
0.21
Independent Variables
Time
0.21***
0.01
0.01***
0.00
2
Time
-0.00***
0.00
-0.00***
0.00
Population Density 0.01***
0.00
-0.00***
0.00
Physical Distancing -0.23***
0.02
-0.20***
0.02
Risk
-2.61
0.24
0.17**
0.05

Diff.
***
***
***
***
***
***

Source: Data are from the European Centre for Disease Control and Prevention, World Bank, Our World in
Data, UNESCO Global Education Coalition, and the World Health Organization
Note: Significance between country types is evaluated using simple linear or logistic regression with HighMortality-Low-Risk as the reference

*p <.05, **p <.01, ***p<.001
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Table 4: Regression Decomposition of Covid-19-Related Case Fatality Rates by Country Type,
January 13 - November 1, 2020 ; N = 4,098

Differential

High-Mortality-Low-Risk Group Prediction
Low-Mortality-High-Risk Group Prediction
Difference

Decomposition
Endowments
Coefficients
Interaction

Coeff.

St. Err.

7.84***
1.54***
6.30***

0.10
0.05
0.12

0.54***
10.65***
-4.90***

0.05
1.63
1.63

Source: Data are from the European Centre for Disease Control and Prevention, World Bank, Our World in
Data, UNESCO Global Education Coalition, and the World Health Organization
*p <.05, **p <.01, ***p<.001
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26

27

32295.12
21.80
4.45
12.90
10.79
50.50

162.34
25376.68

77.24
30071.25
29.30
5.24
19.20
7.17
50.96

157.51
24448.48

72.70

166.92

73.91

33302.81 25114.95
23.70
3.67
21.20
4.78
51.26

33002.17
32.70
6.55
22.00
4.77
50.83

164.59

25958.25

77.06

32652.89
30.60
4.66
19.90
8.31
50.75

163.84

25301.49

76.38

33038.16
22.30
9.11
15.20
4.28
50.66

165.67

25194.61

74.92

Appendix 1: Means and Standard Deviations for Independent and Dependent Variables by Country and Country Type, January 13 - November 1, 2020
High Mortality-Low Risk
United States
Spain
Italy
France
Germany
United Kingdom
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev.
Mean
Std. Dev.
Mean
3.64
1.67
8.32
4.17
11.88
3.39
11.65
6.50
3.18
1.60
10.69
4.90
111814.60
76538.90 24890.69 12455.58 28075.13 13018.00 23361.88 11870.14
6816.10
3655.61 30485.45 16179.78
3263936.00 2828000.00 322840.50 278689.10 226362.10 89102.45 258822.50 283337.20 185490.90 108556.90 275713.80 209427.30
Dependent Variable
Case Fatality Rate (CFR)
Cumulative Deaths
Cumulative Cases
Independent Variables
Time
Time2
Daily Smoking Prevalence
Asthma Prevalence
Percent High Blood Pressure
Diabetes Prevalence
Percent of Total Population Female

Mean PM2.5
9.19
9.96
15.48
11.86
13.45
11.52
36.20
23.80
19.90
21.60
22.30
27.80
Obesity Prevalence
Median Age
38.29
45.50
47.90
42.00
46.59
40.79
Hospital Beds per 1k
2.90
3.00
3.40
6.50
8.30
2.80
Risk
-1.83
0.26
1.40
0.75
1.02
-0.74
Population Density
35.60
93.10
205.85
122.57
237.01
272.89
3.16.2020
3.16.2020
3.10.2020
3.16.2020
3.18.2020
3.20.2020
Physical Distancing Date
Source: Data are from the European Centre for Disease Control and Prevention, World Bank, Our World in Data, UNESCO Global Education Coalition, and the World Health Organization
Note: Asterisks indicate significant difference evaluated using two-tailed independent means t-test by country type
*p <.05, **p <.01, ***p<.001

71.36

170.50

71.74

164.00

7.52
29.40
41.40
2.70
-1.49
4.04
4.01.2020

75.52

165.96

24077.76

70.53

10.51
19.50
43.09
4.70
-0.02
214.24
3.16.2020

32495.62
25.70
6.18
18.00
5.59
50.45

High Mortality-Low Risk
Belgium
Netherlands
Canada
Switzerland
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev.
Mean
11.13
5.03
8.79
4.02
5.55
2.76
3.82
1.61
7935.46 3439.92 4976.20 2214.13 6095.65 3811.71
1370.94
611.30
81920.22 79501.47 67976.56 68093.04 91174.43 60868.17 35319.88 24600.06
171.39

15.23
20.40
43.20
4.70
0.17
508.54
3.16.2020

34447.56 24832.37 34195.50 24889.37 32577.85 25155.86
28.20
25.80
14.30
4.66
7.24
5.77
17.50
18.70
13.20
4.29
5.29
7.37
50.68
50.24
50.38
16.04
22.10
41.79
6.20
0.48
375.56
3.13.2020
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79.64

163.54

76.40

155.08

80.75

167.82

78.77

167.27

77.28

142.91

15.52
15.60
29.90
1.90
-0.28
96.25
3.18.2020

25.02
6.10
42.40
2.40
0.50
7915.73
1.27.2020

23.17
10.10
40.09
2.10
0.48
135.13
3.18.2020

53.85
46.42
43.20
5.40
3.34
6659.00
1.25.2020

22.33
10.30
42.50
6.90
0.55
649.00
2.25.2020

***
***
***
***
***
***
***

***
***
***
***
***

Diff.

***

157.85

***
***
***

79.99

89.64

156.77

Low Mortality-High Risk
South Korea
Japan
Malaysia
Singapore
Thailand
Hong Kong
Taiwan
Mean
Std. Dev.
Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev. Mean
Std. Dev.
1.72
0.67
2.84
1.57
1.19
0.50
0.08
0.10
1.51
0.55
2.01
4.58
1.49
0.82
252.19
128.69
797.38
575.35
103.93
54.53
18.19
11.18
46.59
21.13
36.61
40.15
4.74
2.74
13351.29 7050.05 32803.41 32254.84 8188.19 5872.77 32170.37 23559.51 2764.72 1134.20 2465.94 1929.60
335.36
196.91

13.15
4.10
48.20
13.40
-0.15
347.77
3.02.2020

30951.68 25644.85 31236.53 25597.61 32558.81 25277.94 30547.90 25673.68 34339.97 26030.43 33923.14 25220.58 28397.18 28127.00
23.30
22.10
21.50
16.50
19.90
10.50
17.10
4.58
4.59
4.65
4.55
5.35
4.75
4.89
11.10
17.60
25.30
14.60
22.30
27.30
21.50
6.80
5.72
16.74
10.99
7.04
10.25
10.01
49.96
50.77
48.38
50.59
51.24
35.55
50.31
28.68
4.70
43.40
13.20
-0.12
527.96
3.02.2020
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